Anti-Aging Supplements May Have Same Benefits as Caloric Restriction Diet

Market Wire, July, 2008

It has long been known that a calorie restricted diet can help prevent the conditions frequently associated with aging. However, many doctors and scientists are reluctant to recommend a caloric intake as low as is required as this may also lead to inadequate nutrition which, in turn, can cause other problems. Recent research indicates that anti-aging supplements such as resveratrol may offer the same benefits, without the risks. Feelgoodforlife.com offers additional information on resveratrol and other nutritional supplements.

A recent study, the findings of which were reported online in Cell Metabolism, found that obese and normal weight middle-aged mice given resveratrol experienced reduced cholesterol, less inflammation in the heart, better-functioning aorta, better bone density, reduced formation of cataracts, and enhanced balance and motor coordination.

Although other anti-aging supplements have had similar effects, this one has gained particular interest due to being identified as the health-giving substance in red wine that may be responsible for the low incidence of coronary heart disease in southern France despite a diet high in saturated fats. In the U.S., heart disease is the number one killer and low saturated fat intake is one of the major recommendations made by doctors.

Exactly how resveratrol works is still in question. However, it was also recently reported as effective against nerve cell dysfunction and cell death. This indicates it may help in the fight against Huntington's disease and Alzheimer's, in addition to its many other health benefits.

Additional studies also found that resveratrol reduced the size and number of tumors in the esophegus and prevented or reduced the development of intestinal and colon tumors in rats given carcinogens.

The pharmacuetical industry, which has shown increasing interest in anti-aging supplements and similar products, is also investing in resveratrol. GlaxoSmithKline recently acquired Sirtris Pharmaceuticals for $720 million. Sirtris, whose drug candidates focus on those that mimic the health benefits of caloric restriction without requiring a change in eating habits, is on the leading edge of resveratrol research.

While the jury is still out and there is still much research to be done, resveratrol appears to hold a lot of promise. For more information about resveratrol and other anti-aging supplements, see www.feelgoodforlife.com .

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=794069

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact Media Contact Sally Falkow Sallyf@expansionplus.com 626.793.4911 ext. 105